Close Menu
    Quds SunQuds Sun
    • Automotive
    • Business
    • Entertainment
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Quds SunQuds Sun
    Home » Dante Genomics receives grant for a whole genome sequencing project to measure utility of pharmacogenomics in a real, clinical setting
    PR Newswire

    Dante Genomics receives grant for a whole genome sequencing project to measure utility of pharmacogenomics in a real, clinical setting

    April 27, 2023
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    – Highly coveted Innovation Grant by the Italian Government will measure impact of whole genome sequencing and pharmacogenomics starting from a specific population of cancer patients —

    NEW YORK, April 27, 2023 /PRNewswire/ — Dante Genomics, a global leader in genomics and precision medicine, today announced it has been awarded a highly coveted Innovation Grant from the Italian Government to measure the impact of whole genome sequencing and pharmacogenomics for patients with High Grade Serous Ovarian Cancer (HSOC). The immediate purpose is to measure the clinical utility of whole genome sequencing for this well-defined population of cancer patients in a clinical setting and the benefits for the entire healthcare system.

    Dante Genomics

    “Our shared long-term goal is to create a pathway for the use of whole genome sequencing in real, clinical settings in a national healthcare system,” said Andrea Riposati, Co-founder and CEO of Dante Genomics. “We are starting in Italy, a European Union founding member and G7 country with a population of 60 million people, and in a healthcare system keen to innovate.”

    The grant will fund a patient pilot study in which Dante will provide sequencing, interpretation and genomic reports to demonstrate the validity of whole genome sequencing to support clinicians and their patients throughout all of the steps of the treatment journey from diagnosis to therapy selection and specialty consultation, eventually leading to better health outcomes.

    “Whole genome sequencing for cancer patients can mean all the difference when determining the best treatment plan in a timely manner. By starting with whole genome sequencing, we can offer pharmacogenomics reports available in minutes, determining the best drugs on the market and any resistance to existing therapies. This project with the Italian government will increase access to personalized medicine options for people with High Grade Serous Ovarian Cancer,” said Mattia Capulli, PhD, Co-founder and CSO of Dante Genomics and Associate Professor of Human Embryology and Histology at the University of L’Aquila in Italy.

    The 36-month project has the ambition to set a proof of concept that demonstrates how a deep integration of genomics and bioinformatics in the treatment of oncology patients brings a dramatic improvement of cancer treatment outcomes.

    About Dante Genomics

    Dante Genomics is a global genomic information company building and commercializing a new class of transformative health and longevity applications based on whole genome sequencing and software. The Company uses its platform to deliver better patient outcomes, prevention, enhanced diagnostics and personalized medicine. The Company’s assets include one of the largest private genome databases with research consent, proprietary software designed to unleash the power of genomic data at scale and proprietary processes which enable an industrial approach to genomic sequencing.

    Contact:
    Laura D’Angelo
    VP of Investor Relations
    ir@dantelabs.com
    +39 0862 191 0671
    www.dantegenomics.com

    Logo – https://mma.prnewswire.com/media/2035834/4008003/Dante_Genomics_Logo.jpg

    Cision View original content:https://www.prnewswire.co.uk/news-releases/dante-genomics-receives-grant-for-a-whole-genome-sequencing-project-to-measure-utility-of-pharmacogenomics-in-a-real-clinical-setting-301809210.html

    Related Posts

    TÜV SÜD opens its International Technology & Innovation Campus in the Guangdong-Hong Kong-Macao Greater Bay Area

    November 20, 2026

    Huawei Unveils Financial AI Scaling Capabilities at Singapore FinTech Festival 2026

    November 20, 2026

    UnionPay International and Transsion Announce Global Partnership to Bring UnionPay Payments to T Wallet, Debuting in Pakistan

    November 19, 2026

    Lianlian DigiTech Launches LianLian XWorker, an AI Workforce Platform for Global Commerce

    November 19, 2026

    Getac Expands OS Choice for Highly Regulated Industries with Red Hat® Enterprise Linux® Certification Across Three Fully Rugged Devices

    November 19, 2026

    Sinopec Hosts Side Event at COP31’s CHINA PAVILION, Releases Energy and Green Fuel Outlooks

    November 19, 2026
    Latest News

    Guinea declares mpox outbreak over after 42 days without cases

    November 21, 2026

    Guinea has declared an end to its mpox outbreak after two full incubation periods passed with no new active cases or chains of transmission. The government made the announcement on Thursday, November 19. Health Minister Khaite Sall said in an

    WFP seeks $12.1 billion to feed 91 million people in 2027

    November 21, 2026

    South Korea’s exports pass $1 trillion for the first time

    November 21, 2026

    Air Arabia Egypt launches Cairo to Al Ain flights now

    November 20, 2026

    Botswana opens consultations on proposed 33 percent hike now

    November 19, 2026

    PM Modi meets Prince and Princess of Wales in New Delhi

    November 19, 2026

    Rand slips toward R17 as inflation and weak growth cloud outlook

    November 18, 2026

    DXB handles 50.4 million passengers in first nine months

    November 18, 2026
    © 2026 Quds Sun | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.